Insulin Innovation Dilemma
Scott raises a thought-provoking question about the potential irony of small labs needing to become large corporations to bring innovative insulin to market. Anthony discusses the challenges of navigating regulations and finding the right partners to scale up transformative ideas. The conversation delves into the complexities of maintaining integrity while seeking to revolutionize the insulin market.In this clip
From this podcast
Juicebox Podcast: Type 1 Diabetes
#77 Hacking Insulin
Related Questions